Clinical Trial Update: Phase I Study of Vorinostat and Sorafenib in Advanced Cancer [Phase 1]

View source ↗

Summary

Phase I study update of the combination of vorinostat and sorafenib in patients with advanced cancer, with completed status. Diseases include renal cell carcino…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Renal Cell Carcinoma

Drugs mentioned

• Nexavar (Sorafenib)
• Zolinza (vorinostat)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Malignant Solid Tumour, Renal Cell Carcinoma | Phase 1 | Status: COMPLETED